Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS banner

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E

Watchlist Manager
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Logo
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Watchlist
Price: 4.12 TRY 1.73% Market Closed
Market Cap: ₺2.1B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-38%
5Y
-
10Y
-
Operating Income
+
3Y
-
5Y
-
10Y
-
Net Income
+
3Y
+59%
5Y
-
10Y
-

Earnings Waterfall
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

Income Statement
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

Rotate your device to view
Income Statement
Currency: TRY
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025
Revenue
Interest Expense
2
4
5
5
10
8
9
17
28
37
30
20
22
39
52
0
0
0
Revenue
230
N/A
267
+16%
307
+15%
373
+22%
384
+3%
368
-4%
299
-19%
203
-32%
191
-6%
58
-70%
35
-39%
139
+290%
97
-30%
172
+77%
194
+13%
159
-18%
211
+33%
186
-12%
Gross Profit
Cost of Revenue
(120)
(132)
(156)
(200)
(228)
(224)
(191)
(136)
(126)
(37)
(31)
(113)
(82)
(139)
(147)
(116)
(150)
(124)
Gross Profit
111
N/A
135
+22%
152
+12%
174
+14%
156
-10%
144
-8%
108
-25%
67
-38%
65
-3%
20
-69%
5
-77%
26
+459%
15
-42%
32
+116%
47
+46%
42
-11%
61
+44%
62
+2%
Operating Income
Operating Expenses
(36)
(46)
(44)
(50)
(63)
(57)
(51)
(36)
(84)
(42)
(41)
(79)
(57)
(86)
(112)
(90)
(129)
(127)
Selling, General & Administrative
(29)
(34)
(33)
(37)
(43)
(42)
(41)
(34)
(45)
(20)
(17)
(38)
(28)
(44)
(47)
(38)
(54)
(51)
Research & Development
(4)
(3)
(5)
(6)
(15)
(17)
(16)
(16)
(14)
(7)
(6)
(22)
(15)
(24)
(28)
(22)
(30)
(30)
Depreciation & Amortization
(2)
(2)
(3)
(4)
(3)
(5)
(5)
(5)
(10)
(7)
(5)
(7)
0
0
0
(2)
0
0
Other Operating Expenses
(0)
(5)
(1)
(2)
(3)
8
11
18
(15)
(7)
(13)
(12)
(14)
(18)
(38)
(28)
(45)
(45)
Operating Income
75
N/A
89
+18%
108
+21%
123
+14%
93
-24%
88
-6%
57
-35%
31
-45%
(19)
N/A
(21)
-10%
(37)
-73%
(53)
-44%
(42)
+20%
(54)
-27%
(65)
-21%
(48)
+27%
(69)
-43%
(65)
+5%
Pre-Tax Income
Interest Income Expense
41
47
44
58
61
97
125
223
404
320
222
3
(38)
(23)
(124)
12
207
321
Non-Reccuring Items
(26)
(26)
(26)
(26)
(8)
(8)
(8)
(8)
(0)
(0)
(0)
78
0
0
0
0
0
(0)
Gain/Loss on Disposition of Assets
0
1
1
0
0
1
0
0
0
(0)
0
0
0
0
0
66
0
0
Total Other Income
(3)
(2)
(2)
(2)
0
(1)
(0)
(1)
(212)
0
0
(132)
(119)
(160)
(209)
(82)
45
85
Pre-Tax Income
88
N/A
108
+23%
124
+14%
153
+23%
147
-3%
177
+20%
174
-1%
246
+41%
173
-30%
299
+73%
186
-38%
(105)
N/A
(199)
-90%
(237)
-19%
(397)
-68%
(52)
+87%
183
N/A
341
+86%
Net Income
Tax Provision
(10)
(12)
(17)
(20)
(20)
(38)
(20)
(15)
(37)
4
(12)
2
134
299
311
104
84
(110)
Income from Continuing Operations
78
96
107
132
127
139
154
231
136
303
173
(103)
(66)
62
(87)
52
267
231
Income to Minority Interest
(17)
(20)
(20)
(20)
(13)
(15)
(9)
(8)
20
0
0
0
0
0
0
0
0
0
Net Income (Common)
61
N/A
76
+25%
87
+13%
113
+30%
114
+2%
124
+8%
146
+18%
223
+53%
156
-30%
302
+94%
174
-43%
(103)
N/A
(66)
+36%
62
N/A
(87)
N/A
52
N/A
267
+412%
231
-14%
EPS (Diluted)
0.68
N/A
0.8
+18%
0.9
+12%
1.03
+14%
1.14
+11%
1.22
+7%
1.45
+19%
2.23
+54%
0.31
-86%
3.02
+874%
0.34
-89%
-0.21
N/A
-0.66
-214%
0.62
N/A
-0.87
N/A
0.1
N/A
0.53
+430%
0.46
-13%

See Also

Summary
RTALB.E intrinsic value, competitors valuation, and company profile.
DCF Valuation
RTALB.E stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RTALB.E stock valuation using valuation multiples.
Wall Street Estimates
RTALB.E price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RTALB.E stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.